Peptide Center / Ipamorelin
Not FDA-approvedIpamorelin: evidence, status & safety
Ipamorelin is a growth-hormone secretagogue promoted for recovery, muscle, sleep and anti-aging. It is not an FDA-approved drug.
What patients should know first
| Commonly discussed for | Selective GH release with fewer adverse effects than other secretagogues. |
| What efficacy data show | No high-quality clinical program establishes efficacy for outpatient anti-aging, body composition, athletic recovery or longevity. |
| Approval boundary | Claims of receptor selectivity do not establish a safe dose, appropriate population, long-term outcome or quality standard for compounded injections. |
| Safety context | FDA identifies potential immunogenicity and peptide-impurity concerns. FDA also cites serious adverse events, including death, in a study using intravenous ipamorelin for gastric motility; other routes and causality require context, but safety for marketed wellness use is not established. |
Do not confuse a molecule with a verified medication
The name of an active ingredient does not verify the product in a vial. FDA approval, when it exists, applies to a specific product and indication. A compounded version is not FDA-approved, and a research-labeled product is not approved for human use.
Clinical supervision should include diagnosis, contraindication and interaction review, realistic outcome discussion, a valid prescription, traceable sourcing and follow-up. It cannot make an anonymous or counterfeit product safe.
Questions to ask
- Is there an FDA-approved product for my exact condition?
- What human outcome—not only biomarker—supports this use?
- What are the important contraindications and stopping rules?
- Which licensed pharmacy will dispense the prescription?
- How will response and adverse effects be monitored?
Verify the evidence
Know the status.
Verify the source.
This guide is educational and cannot determine whether Ipamorelin is appropriate for you.
Move from information to the right next step.
Explore connected treatment guidance, meet the clinical team or begin a personalized consultation.
Patient education developed from primary regulatory, labeling and professional sources.
Chief Medical Officer – Texas · Aesthetic medicine, hormone optimization and peptide therapy.
